[go: up one dir, main page]

GR3019699T3 - Pharmaceutical compositions for the treatment of b-cell malignancies - Google Patents

Pharmaceutical compositions for the treatment of b-cell malignancies

Info

Publication number
GR3019699T3
GR3019699T3 GR960401082T GR960401082T GR3019699T3 GR 3019699 T3 GR3019699 T3 GR 3019699T3 GR 960401082 T GR960401082 T GR 960401082T GR 960401082 T GR960401082 T GR 960401082T GR 3019699 T3 GR3019699 T3 GR 3019699T3
Authority
GR
Greece
Prior art keywords
cell malignancies
pharmaceutical compositions
treatment
cell
treating
Prior art date
Application number
GR960401082T
Other languages
English (en)
Inventor
Jacques Banchereau
France Thierry De
Original Assignee
Schering Plough Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Corp filed Critical Schering Plough Corp
Publication of GR3019699T3 publication Critical patent/GR3019699T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • A61K38/2026IL-4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR960401082T 1990-12-13 1996-04-22 Pharmaceutical compositions for the treatment of b-cell malignancies GR3019699T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90403585A EP0490006B1 (en) 1990-12-13 1990-12-13 Pharmaceutical compositions for the treatment of B-cell malignancies
PCT/EP1991/002380 WO1992010201A1 (en) 1990-12-13 1991-12-10 Pharmaceutical compositions for the treatment of b-cell malignancies

Publications (1)

Publication Number Publication Date
GR3019699T3 true GR3019699T3 (en) 1996-07-31

Family

ID=8205785

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960401082T GR3019699T3 (en) 1990-12-13 1996-04-22 Pharmaceutical compositions for the treatment of b-cell malignancies

Country Status (16)

Country Link
EP (2) EP0490006B1 (el)
JP (1) JPH06504767A (el)
AT (1) ATE135232T1 (el)
AU (1) AU9072191A (el)
CA (1) CA2098509A1 (el)
CZ (1) CZ113593A3 (el)
DE (1) DE69117974T2 (el)
DK (1) DK0561927T3 (el)
ES (1) ES2084995T3 (el)
FI (1) FI932650L (el)
GR (1) GR3019699T3 (el)
HU (1) HU210009B (el)
IE (1) IE64157B1 (el)
OA (1) OA09788A (el)
SK (1) SK59193A3 (el)
WO (1) WO1992010201A1 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2711182B2 (ja) * 1992-08-19 1998-02-10 シェリング・コーポレーション Il−4を用いるhiv複製を阻害する方法
US5679338A (en) * 1994-05-12 1997-10-21 Osteoarthritis Science, Inc. Use of IL-4 for inhibition of the breakdown of articular cartilage and other tissues
US5716612A (en) * 1994-09-07 1998-02-10 Schering Corporation Use of IL-4 for potentiation of chemotherapeutic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0552243B1 (en) * 1990-09-06 1996-11-27 Schering Corporation Use of il-4 to treat solid tumors

Also Published As

Publication number Publication date
IE64157B1 (en) 1995-07-12
CZ113593A3 (en) 1994-01-19
FI932650A0 (fi) 1993-06-10
DE69117974D1 (de) 1996-04-18
FI932650L (fi) 1993-06-10
EP0490006B1 (en) 1994-06-22
DK0561927T3 (da) 1996-07-29
IE914328A1 (en) 1992-06-17
DE69117974T2 (de) 1996-07-25
ATE135232T1 (de) 1996-03-15
CA2098509A1 (en) 1992-06-14
EP0561927A1 (en) 1993-09-29
WO1992010201A1 (en) 1992-06-25
JPH06504767A (ja) 1994-06-02
ES2084995T3 (es) 1996-05-16
AU9072191A (en) 1992-07-08
EP0490006A1 (en) 1992-06-17
EP0561927B1 (en) 1996-03-13
SK59193A3 (en) 1994-01-12
HUT64478A (en) 1994-01-28
HU9301719D0 (en) 1993-09-28
HU210009B (en) 1995-01-30
OA09788A (en) 1994-04-15

Similar Documents

Publication Publication Date Title
ES8801204A1 (es) Un procedimiento para la preparacion de derivados de indol
AU2118488A (en) Improvements in or relating to methods of treating damaged skin
AU1808488A (en) Compounds for the treatment of alzheimer's disease
SG45280A1 (en) Methods for inhibiting smooth muslce cell proliferation and restinosis
GR3017996T3 (en) 17-g(b)-SUBSTITUTED-4-AZA-5-g(a)-ANDROSTAN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION.
BG104089A (en) Dolastatine 15 derivatives
PL307914A1 (en) Lipopetide derivatives, method of obtaining them and therapeutic agents containing such compounds
GR3022321T3 (en) Use of il-4 to treat solid tumors
HU910930D0 (en) Process for the production of 2,8-dioxa-bicyclo/3.2.1/octane derivatives and medical preparations containing them
IN167848B (el)
FI934680A0 (fi) Arylmorfolin, framstaellning och anvaending
GR3019699T3 (en) Pharmaceutical compositions for the treatment of b-cell malignancies
IL105475A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS
MY104521A (en) Treatment of depression.
PH22424A (en) (1-arylcyclobutly)-(heterocyclyl)-methylamine compounds useful as therapeutic agents
DE2966809D1 (en) 3,4-diaza-bicyclo(4.1.0)hepten-2-ones-5, process for their preparation and therapeutical compositions containing them
EP0909759A3 (en) Individual stereoisomers of 7-(3-aminoalkyl)-1-pyrrolidinyl)-quinolones as antibacterial agents
HUT70757A (en) Pharmaceutical compositions for treating skin disorders
JPS5695116A (en) Xanthine oxidase inhibitor and therapeutic treatment thereby
DE3362725D1 (en) Carbamyloxybenzhydrole derivatives, process for their preparation and pharmaceutical compositions containing them
TW222622B (el)
NZ503027A (en) Use of rifamycin derivative for treating mastitis in a domestic animal
AU2060783A (en) Morphine-vitamin b12 analgesic treatment
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
IE880246L (en) TRIAZOLO £3,2-b| £1,2,4| TRIAZIN-7-ONES